Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 167, Issue 1, Pages 87-99
Publisher
Wiley
Online
2014-07-04
DOI
10.1111/bjh.13011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target
- (2013) Yang Yang et al. CANCER LETTERS
- Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia
- (2013) E J Gang et al. ONCOGENE
- Inhibition of androgen receptor and -catenin activity in prostate cancer
- (2013) E. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
- (2012) T. Bhatla et al. BLOOD
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
- (2011) L. E. Hogan et al. BLOOD
- Endogenous knockdown of survivin improves chemotherapeutic response in ALL models
- (2011) D J Morrison et al. LEUKEMIA
- Outcome after first relapse in children with acute lymphoblastic leukemia: A report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol
- (2011) H. van den Berg et al. PEDIATRIC BLOOD & CANCER
- An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
- (2011) F. C. Gonsalves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- Identification ofptproas a novel target gene of Wnt signaling and its potential role as a receptor for Wnt
- (2010) Minseong Kim et al. FEBS LETTERS
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway
- (2010) Christophe Fuerer et al. PLoS One
- The Wnt/ -Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
- (2010) Y. Wang et al. SCIENCE
- Structure–activity relationship studies of small-molecule inhibitors of Wnt response
- (2009) Jianming Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options
- (2009) Iris Gehrke et al. EUROPEAN JOURNAL OF CANCER
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
- (2008) Elizabeth A. Raetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
- (2008) K Nguyen et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started